Qihan Biotech Stock

Qihan Biotech is a gene-editing organ transplantation technology developer.

Sign up today and learn more about Qihan Biotech Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Qihan Biotech Stock

Qihan Biotech is a biomedical company based on genetic technology. Kaixin Bio ’s mission is to create a new world where patients do n’t have to wait for organ transplants. We are committed to using the world's advanced gene editing technology to produce safe and effective cells, tissues and organs that can be used for human transplantation, and to solve the serious shortage of organ transplant donors in China and the world.

Funding History

July 2018$7.8M
September 2019$25.5M
March 2021$67.0M
September 2023$16.0M


Founder and CEO

Luhan Yang


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: